Artificial intelligence is transforming healthcare, and the potential is immense. Detecting cancer months earlier than the human eye can. Tailoring treatment to each patient’s unique genetic profile. Freeing healthcare providers from repetitive tasks so they can focus on what matters most: their patients. Making medical expertise accessible even in the most remote regions. And above all, shifting medicine from a curative model to a truly preventive approach, where we anticipate disease rather than merely treating it.
This potential is no longer the stuff of science fiction. Around the world, hospitals, researchers, and medical innovation companies are already deploying artificial intelligence solutions in healthcare that are tangibly improving diagnoses, treatments, and care management.
But there is a gap—one that is often underestimated—between an impressive demonstration and technology that truly changes the daily lives of healthcare professionals. Realizing this promise depends not only on the power of algorithms but also on how AI integrates into the real world of healthcare.
This article explores the topic in depth: what AI in healthcare really is, its main applications, its benefits for both patients and healthcare professionals, its ethical challenges, and what distinguishes a promising project from a solution that makes a lasting difference.
Medical artificial intelligence refers to all technologies capable of analyzing health data to help understand, predict, or make decisions. This general term encompasses several levels.
In healthcare, these technologies are applied to a wide variety of data: medical imaging (X-rays, CT scans, MRIs), patient records, lab results, physiological signals, and genetic data.
Not all software used in healthcare falls under the umbrella of artificial intelligence. A medical record management system, a database, or an automation tool performs a predefined task without ever “learning.” It stores, organizes, or executes instructions.
What sets medical AI apart is its ability to learn and support decision-making. It doesn’t just execute tasks—it identifies trends, detects anomalies, formulates hypotheses, and improves over time.
This distinction has an important practical implication: AI does not replace existing digital tools; rather, it complements them. It adds a layer of intelligence on top of the systems already in place at healthcare facilities. And it is precisely this integration with existing systems that largely determines its true value.
Medical AI is not just a distant promise—it is already being used in many areas of the healthcare system. Here are the most common applications.
This is the most mature application. By analyzing medical imaging (X-rays, CT scans, MRIs), algorithms identify abnormalities that are sometimes invisible to the human eye and help detect certain conditions earlier. This is not a niche application: the U.S. FDA has approved more than 1,300 medical devices equipped with AI, nearly 80% of which are in radiology. When dealing with complex cases, AI can also analyze a volume of information that no human could process in real time and support clinical decision-making: it acts as a second reader who prioritizes urgent cases and flags suspicious areas. The final decision remains with the physician.
By cross-referencing clinical, genetic, and behavioural data, AI helps identify disease risks before they manifest. It enables us to anticipate the progression of at-risk patients, personalize prevention plans, and even support epidemiological surveillance. This is at the heart of the shift toward a model of medicine that focuses on prevention rather than cure.
AI makes it possible to tailor treatments to each patient’s unique profile. By cross-referencing clinical, genetic, and behavioural data, it helps select the therapy most likely to work for a given individual, rather than relying on a standardized approach. This marks a shift from medicine designed for the “average patient” to medicine tailored to the individual, which improves treatment effectiveness while reducing unsuccessful trials.
AI accelerates the identification of new molecules and the analysis of clinical trials, thereby reducing the costs and time required for drug development. The contrast with traditional methods is striking: whereas drug design typically takes several years, some platforms have identified a drug candidate in about 12 months. An AI-designed treatment for pulmonary fibrosis has thus reached Phase II clinical trials, with positive results published in *Nature Medicine* in 2025.
A significant portion of medical and administrative staff’s time is consumed by paperwork: billing, document processing, and scheduling. This is often where AI delivers its fastest and most tangible benefits. Automation of administrative tasks, bed management, staff scheduling, and forecasting emergency room patient flow—all of these functions free up time for patient care itself.
This challenge isn’t unique to healthcare. In the insurance sector, a project led by Nexapp’s teams in collaboration with the InsurTech Azimut Lab made it possible to automate, using AI, the processing of a massive volume of billing documents—a task that was both time-consuming and repetitive for the teams. The logic is exactly the same as in a hospital setting: as soon as a labour-intensive, standardizable document-processing task can be entrusted to AI, professionals free up time for what really matters.
Thanks to connected devices (watches, sensors), AI enables remote monitoring of chronic conditions, with automatic alerts in the event of an anomaly. This provides a concrete solution to the challenge of continuous monitoring, particularly in areas with a shortage of medical staff.
All these applications share a promising vision: when seamlessly integrated into everyday tools, AI frees up time, refines decision-making, and tangibly improves care. It is on the ground, working alongside teams, that its full value becomes apparent.
Beyond technical applications, it is the tangible benefits that matter—for both those receiving care and those providing it.
The potential of AI in healthcare must not overshadow the responsibilities it entails. Poorly designed or poorly regulated AI can cause harm. Recognizing these challenges is precisely what is needed to deploy the technology safely and sustainably.
AI is only as good as the data it was trained on. Incomplete, poorly documented, or non-representative data can lead to inaccurate conclusions—or even unfair decisions for certain patient groups. The reliability of medical AI therefore begins long before the technology itself: in the quality and representativeness of the data that powers it.
No AI is infallible: it can produce false positives (flagging a nonexistent abnormality) or false negatives (missing a real problem). Hence the importance of rigorous clinical validation before any deployment.
Good AI is, in fact, designed to recognize its own limitations. Rather than processing everything at all costs, well-designed tools incorporate checkpoints: clear-cut cases are processed automatically, while complex or ambiguous situations are referred to a human. This approach involves accepting a reduction in the proportion of cases handled by AI to maximize overall reliability: a deliberate trade-off between speed and safety, which is particularly crucial when decisions have a direct impact on people.
There is also the issue of transparency: we must be able to understand the basis for the AI’s recommendation in order to avoid the “black box” effect of an unexplained decision. And in the event of an error, who is responsible: the doctor, the healthcare facility, or the tool’s developer? This gray area remains one of the major challenges in medical AI.
Health data is among the most sensitive information there is. Its processing by AI must comply with a strict framework. In Quebec, two laws apply:
In addition, there are practical considerations: data residency (where is it hosted and stored?), informed patient consent, and IT security against cyberattacks. For organizations targeting an international market, the European GDPR imposes comparable requirements.
Medicine is not just about data. Listening, empathy, the ability to deliver difficult news, or to take a person’s overall context into account—these are things no machine can do. AI must remain an assistant that supports healthcare professionals, never a substitute for the patient-care relationship.
As AI becomes more deeply embedded in everyday practices, a risk emerges: the gradual loss of certain skills if we rely too systematically on machines. The challenge is to make AI a tool that enhances professionals’ expertise, without ever stripping them of their ability to exercise judgment. The final decision must always rest with humans.
It’s never been easier to produce an impressive AI demo. The tools have become widely accessible, and it sometimes takes just a few weeks to create a prototype that wows. True success, however, is measured by something else: a solution that tangibly changes the daily lives of professionals and has an impact on the organization’s results.
What does it take to reach this stage? Four key factors make all the difference:
Together, these four conditions transform a promising project into a solution that creates lasting value on the ground, benefiting both teams and patients.
In the insurance sector, Nexapp helped Azimut Lab, which was struggling with the manual processing of a massive volume of billing documents—with each policy requiring up to 45 minutes of administrative work.
We designed a solution tailored to real-world needs: integrated with existing systems to ensure business continuity, capable of automatically transferring complex cases to a human to maintain impeccable reliability, and robust enough for the client to scale it independently.
The result: a practical solution delivered in two months and a return on investment achieved in six months. The same approach—entrusting repetitive tasks to AI to free up time for humans—applies directly to administrative challenges in the healthcare sector.
AI in healthcare is still in its infancy. Several developments, already underway, are shaping the future of medicine.
This acceleration comes with a requirement: to establish a regulatory framework. Medical software equipped with AI calls for clear guidelines regarding its safety, transparency, and accountability in the event of an error. Regulatory authorities, in Quebec as elsewhere, are working to adapt their regulatory frameworks to these technologies. Far from stifling innovation, this regulation is a prerequisite for it: it is what builds the trust necessary for widespread and sustainable adoption.
Artificial intelligence represents one of the most promising advances for the future of healthcare. By helping to detect diseases earlier, personalize treatments, free up time for healthcare providers, and expand access to care, it paves the way for a more preventive, personalized, and accessible healthcare system.
But this promise won’t be fulfilled on its own. Artificial intelligence in healthcare performs at its best when it is truly integrated into the daily work of healthcare teams, within a framework of sound ethical, medical, and regulatory standards. Its value is not measured in the laboratory, but in the field: in its ability to integrate into existing systems, to adapt to real-world constraints, and to free up time for healthcare professionals.
The goal has never been to replace humans. It is to equip them so they can make better, faster decisions and focus on what really matters: patient care and the patient-caregiver relationship. Only then will AI deliver on its promises.
Artificial intelligence in healthcare refers to all technologies capable of analyzing medical data (imaging, patient records, lab results, genetic data) to help understand, predict, or make decisions. Unlike traditional digital tools, which simply store or execute tasks, AI learns from data and improves its performance over time.
There are many applications: analyzing medical images to detect abnormalities, predictive medicine to anticipate disease risks, personalized treatments, accelerating drug discovery, automating administrative tasks, and remote patient monitoring via connected devices.
AI can assist with diagnosis by flagging abnormalities and prioritizing urgent cases, but it does not make a diagnosis on its own. It serves as a decision-support tool: it is the doctor who interprets the results, takes the patient’s overall context into account, and makes the final decision.
The main risks relate to data quality (biased data can skew results), the risk of error, the protection of personal information, and liability in the event of a failure. That is why rigorous clinical validation, a robust regulatory framework, and ensuring that humans remain involved in decision-making are essential.
No. AI is a tool to assist doctors, not a substitute for them. Human expertise remains essential: the relationship with the patient, clinical judgment, empathy, consideration of the overall context, and the final decision. AI frees up time and supports healthcare professionals, but it does not replace their role or responsibility.
Protection rests on several pillars: compliance with legal frameworks (in Quebec, Bill 25 and Bill 5), storing data in a secure environment, informed patient consent, and robust IT security measures against cyberattacks. These requirements are all the more crucial given that health data is among the most sensitive types of data.